Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Vraylar® (cariprazine) – New indication
May 28, 2019 - Allergan and Gedeon Richter announced the FDA approval of Vraylar (cariprazine), for treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
